Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion

K Tatemoto, S Efendić, V Mutt, G Makk, GJ Feistner… - Nature, 1986 - nature.com
K Tatemoto, S Efendić, V Mutt, G Makk, GJ Feistner, JD Barchas
Nature, 1986nature.com
In mammalian tissues the C-terminal amide structure has been found to occur only in
neuroactive or hormonally-active peptides1. About half known neuropeptide and peptide
hormones have this unique chemical feature. Using a chemical detection method2, a search
for previously unknown peptides that possess the C-terminal amide structure in extracts of
brain and intestine was carried out3 and a number of novel neuropeptides and hormonal
peptides4, designated neuropeptide Y5, 6, PHI7, peptide YY8, galanin9 and neuropeptide …
Abstract
In mammalian tissues the C-terminal amide structure has been found to occur only in neuroactive or hormonally-active peptides1. About half known neuropeptide and peptide hormones have this unique chemical feature. Using a chemical detection method2, a search for previously unknown peptides that possess the C-terminal amide structure in extracts of brain and intestine was carried out3 and a number of novel neuropeptides and hormonal peptides4, designated neuropeptide Y5,6, PHI7, peptide YY8, galanin9 and neuropeptide K10 were isolated. We recently performed a similar search in porcine pancreas and found a high concentration of a peptide having a glycine amide at its C-terminus. Here we report the isolation, primary structure and biological activity of this novel peptide. The 49-residue peptide strongly inhibits glucose-induced insulin release from the isolated perfused pancreas and was therefore named pancreastatin. It may be important in the regulation of insulin secretion and in the pathogenesis and treatment of diabetes mellitus.
nature.com